Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Clinical trial NCT06419673 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06419673
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-05-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.